- Home
- OFLX vs GHRS Comparison
OFLX vs GHRS Comparison
Compare OFLX & GHRS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OFLX
- GHRS
- Stock Information
- Founded
- OFLX 1975
- GHRS 2018
- Country
- OFLX United States
- GHRS Ireland
- Employees
- OFLX N/A
- GHRS N/A
- Industry
- OFLX Industrial Specialties
- GHRS Biotechnology: Pharmaceutical Preparations
- Sector
- OFLX Industrials
- GHRS Health Care
- Exchange
- OFLX Nasdaq
- GHRS Nasdaq
- Market Cap
- OFLX 527.8M
- GHRS 470.3M
- IPO Year
- OFLX 2005
- GHRS 2021
- Fundamental
- Price
- OFLX $48.74
- GHRS $9.62
- Analyst Decision
- OFLX
- GHRS Strong Buy
- Analyst Count
- OFLX 0
- GHRS 3
- Target Price
- OFLX N/A
- GHRS $35.67
- AVG Volume (30 Days)
- OFLX 16.7K
- GHRS 71.7K
- Earning Date
- OFLX 10-30-2024
- GHRS 11-14-2024
- Dividend Yield
- OFLX 2.78%
- GHRS N/A
- EPS Growth
- OFLX N/A
- GHRS N/A
- EPS
- OFLX 1.81
- GHRS N/A
- Revenue
- OFLX $102,863,000.00
- GHRS N/A
- Revenue This Year
- OFLX N/A
- GHRS N/A
- Revenue Next Year
- OFLX N/A
- GHRS N/A
- P/E Ratio
- OFLX $27.35
- GHRS N/A
- Revenue Growth
- OFLX N/A
- GHRS N/A
- 52 Week Low
- OFLX $43.86
- GHRS $5.05
- 52 Week High
- OFLX $85.92
- GHRS $14.99
- Technical
- Relative Strength Index (RSI)
- OFLX 39.03
- GHRS 58.95
- Support Level
- OFLX $53.04
- GHRS $8.50
- Resistance Level
- OFLX $53.50
- GHRS $11.09
- Average True Range (ATR)
- OFLX 1.62
- GHRS 0.90
- MACD
- OFLX -0.60
- GHRS 0.14
- Stochastic Oscillator
- OFLX 1.41
- GHRS 56.20
About OFLX Omega Flex Inc.
Omega Flex Inc is a manufacturer of flexible metal hoses, which is used in a variety of ways to carry gases and liquids within their particular applications. Omega sells its products under the TracPipe, CounterStrike, DoubleTrac, DEF-Trac and MediTrac brands. It serves various markets which include construction, manufacturing, transportation, petrochemical, pharmaceutical, and other industries. Geographically Omega Flex, Inc operates in the United States.
About GHRS GH Research PLC
GH Research PLC is a clinical-stage biopharmaceutical company dedicated to transforming the treatment of psychiatric and neurological disorders. The company is focused on developing novel and proprietary Mebufotenin 5-Methoxy-N, N-Dimethyltryptamine, or 5-MeO-DMT, therapies for the treatment of patients with Treatment-Resistant Depression, or TRD.